Brazil Pharmaceuticals and Healthcare Report Q1 2014

LONDON, April 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Brazil Pharmaceuticals and Healthcare Report Q1 2014

Includes 3 FREE quarterly updates

BMI View:

Brazil's traditional commitment to healthcare improvement and growing middle-class
population present significant revenue-generating opportunities for multinationals in the country. The
Brazilian pharmaceutical market is now an integral part of all large pharmaceutical companies' strategic
outlook. However, given the significant influence of the Brazilian government in the pharmaceutical sector
and its determination to promote the domestic pharmaceutical industry, we believe local drugmakers will
outpace multinationals.

Headline Expenditure Projections

• Pharmaceuticals: BRL52.4bn (US$26.8bn) in 2012 to BRL57.0bn (US$26.4bn) in 2013; +8.7% in local
currency terms and -1.6% in US dollars terms. Forecast revised downwards from Q413 due to
macroeconomic forecast changes.
BMI Industry View 7
SWOT 9
Political 11
Economic 12
Business Environment 13
Industry Forecast 14
Pharmaceutical Market Forecast 14
Table: Brazil Pharmaceutical Sales, Historical Data And Forecasts 15
Healthcare Market Forecast 16

Table: Brazil Healthcare Expenditure Trends, Historical Data And Forecasts18
Table: Brazil Government Healthcare Expenditure Trends, Historical Data And Forecasts 18
Table: Brazil Private Healthcare Expenditure Trends, Historical Data And Forecasts19
Prescription Drug Market Forecast 20
Table: Brazil Prescription Drug Market Indicators, Historical Data And Forecasts21
Patented Drug Market Forecast 22
Table: Brazil Patented Drug Market Indicators, Historical Data And Forecasts 23
Generic Drug Market Forecast 24
Table: Brazil Generic Drug Market Indicators, Historical Data And Forecasts 29
OTC Medicine Market Forecast 30
Table: Brazil Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts 31
Pharmaceutical Trade Forecast 32
Table: Brazil Pharmaceutical Trade Data And Forecasts (US$mn) 35
Table: Brazil Pharmaceutical Trade Data And Forecasts (BRLmn) 35
Other Healthcare Data 36
Key Risks To BMI's Forecast Scenario 37
Macroeconomic Forecasts 38
Economic Analysis 38
Table: BRAZIL - ECONOMIC ACTIVITY44

Industry Risk Reward Ratings 45
Americas Risk/Reward Ratings 45
Brazil Risk/Reward Ratings 50
Rewards 50
Risks 50
Market Overview 52
Industry Trends And Developments 54
Epidemiology 54
Healthcare Sector 57
Research & Development 61
Table: Brazilian Government's Partnership Deals With Multinationals 62
Biotechnology 65
Clinical Trials 71
Regulatory Development 73
Regulatory Development 73
Intellectual Property Regime 75
Counterfeits 78
Compulsory Licensing 79
Pricing Regime 80

Reimbursement Regime 84
OTC Regulations 86
Advertising 88
Protectionist Measures 88
Competitive Landscape 92
Table: Top 20 Pharmaceutical Companies In Brazil By Sales In 2010 92
Innovative Drugmakers 93
Generic Drugmakers 101
Table: Hypermarcas' Major Acquisitions, 2005-11 104
OTC Sector 106
Pharmaceutical Distribution Sector 106
Pharmaceutical Retail Sector 109
Company Profile 113
Aché/Biosintética 113
EMS Sigma 117
Eurofarma 120
Medley 123
Cristália 126
Sanofi 129
Pfizer 133
Merck & Co 137
Novartis 141
GlaxoSmithKline 145
Table: GSK'S Strong Collaborative Efforts In Public-Private Partnerships (Ppps) In Brazil148
Roche 149
Demographic Forecast 152
Table: Brazil's Population By Age Group, 1990-2020 ('000)153

Table: Brazil's Population By Age Group, 1990-2020 (% of total)154
Table: Brazil's Key Population Ratios, 1990-2020 155
Table: Brazil's Rural And Urban Population, 1990-2020 155
Glossary 156
Methodology 158
Pharmaceutical Expenditure Forecast Model 158
Healthcare Expenditure Forecast Model 158
Notes On Methodology 159
Risk/Reward Ratings Methodology 160
Ratings Overview 161
Table: Pharmaceutical Risk/Reward Ratings Indicators 161
Indicator Weightings 162

Read the full report:
Brazil Pharmaceuticals and Healthcare Report Q1 2014
http://www.reportbuyer.com/pharma_healthcare/country_reports_pharmaceutical/brazil_pharmaceuticals_healthcare_report_q1.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]  
Tel: +44 208 816 85 48 
Website: www.reportbuyer.com

SOURCE ReportBuyer